Secondary Precursor T-Cell Lymphoblastic Lymphoma Following Precursor B-cell Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature

Although relapse of lymphoma/leukemia is not uncommon, sequential development of a second lymphoma/leukemia of a different cell lineage is rare. We report the case of a 3-year-old girl who initially presented with precursor B-cell acute lymphoblastic leukemia (B-ALL), characterized by a cryptic t(12;21) with associated ETV6/RUNX1 fusion, an 11q (MLL) deletion, and a balanced inv(2)(q31q37). She was successfully treated but five years later developedthymicprecursor T-cell lymphoblastic lymphoma (T-LBL) expressing a completely different phenotypic profile. Fluorescence in situ hybridization testing identified a MLL rearrangement but indicated no ETV6/RUNX1 fusion. Although the marrow was uninvolved, aspirates evaluated by chromosome studies revealed the same inv(2q), suggesting a constitutional abnormality distinct from the somatic alterations associated with her B-ALL and T-LBL. This raisesthe possibilityof a potential tumor suppressor gene or proto-oncogene residing in the region of the inversion breakpoints which could contribute to predisposition to the development of lymphoblastic leukemias/lymphomas. While secondary leukemia may emerge as a therapy-related process and the presence of an MLL rearrangement in the T-LBL represents an interesting abnormality in this regard,athymicpresentation would be exceedingly unusual. To our knowledge, this is the first reported case of B-ALL followed by an apparently genetically unrelatedT-LBL

[1]  R. Marschalek,et al.  Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach. , 2013, Cancer letters.

[2]  S. Raimondi,et al.  Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Moorman The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. , 2012, Blood reviews.

[4]  S. Raimondi,et al.  Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. , 2009, Blood.

[5]  Christa Lese Martin,et al.  Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  M. Busslinger,et al.  Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors , 2007, Nature.

[7]  E. Clappier,et al.  Childhood secondary ALL after ALL treatment , 2007, Leukemia.

[8]  R. Rezsohazy,et al.  Mutation analysis of the HOX paralogous 4–13 genes in children with acute lymphoid malignancies: Identification of a novel germline mutation of HOXD4 leading to a partial loss‐of‐function , 2005, Human mutation.

[9]  J. Mulley,et al.  The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene , 2004, Journal of Human Genetics.

[10]  C. Sklar,et al.  Second cancers in survivors of childhood cancer , 2002, Nature Reviews Cancer.

[11]  M. Alashari,et al.  Therapy-related T cell lymphoblastic lymphoma with t(11;19)(q23;p13) and MLL gene rearrangement , 1999, Leukemia.

[12]  M. Nair,et al.  Acute lymphoblastic leukemia occurring as a second malignancy: report of a case and review of literature. , 1999, Pediatric hematology and oncology.

[13]  J. Pedersen‐Bjergaard Acute lymphoid leukemia with t(4;11) (q21;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II. , 1992, Leukemia research.

[14]  M. Krzywinski,et al.  New insights to the MLL recombinome of acute leukemias , 2009, Leukemia.